Cited by 1,317Cancer Genomics and DiagnosticsPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Open access

Campbell, Peter J., Yachida, Shinichi, Mudie, Laura J., Stephens, Philip J., Pleasance, Erin D., Stebbings, Lucy A., Morsberger, Laura A., Latimer, Calli, McLaren, Stuart, Lin, Meng-Lay, McBride, David J., Varela, Ignacio, Nik-Zainal, Serena A., Leroy, Catherine, Jia, Mingming, Menzies, Andrew, Butler, Adam P., Teague, Jon W., Griffin, Constance A., Burton, John, Swerdlow, Harold, Quail, Michael A., Stratton, Michael R., Iacobuzio-Donahue, Christine, Futreal, P. Andrew·2010·Nature

DOI 10.1038/nature09460PMC PMC3137369

Open this paper in CoChat — free account

Abstract

Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations, but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours, including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites, and how the tumour disseminates. Here we harness advances in DNA sequencing to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature09460

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Self-citation
Mapping short DNA sequencing reads and calling variants using mapping quality scores
Li, H., Ruan, J., & Durbin, R. (2008) · Genome Research · doi:10.1101/gr.078212.108 · Cited by 2,638
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Self-citation
THE STABILITY OF BROKEN ENDS OF CHROMOSOMES IN ZEA MAYS
McClintock, B. (1941) · Genetics · doi:10.1093/genetics/26.2.234 · Cited by 1,605
Pancreatic cancer biology and genetics
Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,175
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2627 · Cited by 1,161
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,144
A small-cell lung cancer genome with complex signatures of tobacco exposure
Pleasance, E., Stephens, P. J., O’Meara, S., McBride, D. J., Meynert, A. M., Jones, D., Lin, M., Beare, D. M., Lau, K. W., Greenman, C., et al. (2009) · Nature · doi:10.1038/nature08629 · Cited by 1,076
Self-citation
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J. S., Prentice, L., Pugh, T. J., Burleigh, A., Delaney, A. D., Gelmon, K. A., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,063

Flagged first, then by citations

Show all 30 references

Sorted by citations

Items 701–800 of 1,000

Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples
Semaan, A., Bernard, V., Lee, J. J., Wong, J., Huang, J. H., Swartzlander, D. B., Stephens, B. M., Monberg, M. E., Weston, B. R., Bhutani, M. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2667 · Cited by 25
Pancreatic cancer genomics: insights and opportunities for clinical translation
Makohon-Moore, A. P., Brosnan‐Cashman, J. A., & Iacobuzio–Donahue, C. A. (2013) · Genome Medicine · doi:10.1186/gm430 · Cited by 25
Self-citation
Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma
Jiang, W., Dulaimi, E., Devarajan, K., Parsons, T. M., Wang, Q., Liao, L., Cho, E.-A., O’Neill, R., Solomides, C., Peiper, S. C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164554 · Cited by 24
Recent advances in the management of pancreatic adenocarcinoma
Karakaş, Y., Laçin, Ş., & Yalçın, Ş. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1403319 · Cited by 24
Intratumor Heterogeneity and Branched Evolution
Bambury, R. M., Power, D. G., & O’Reilly, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1204069 · Cited by 24
Integration of genomic information in the clinical management of HCC
Quetglas, I. M., Moeini, A., Pinyol, R., & Llovet, J. M. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.004 · Cited by 23
Novel three‐way complex rearrangement of TRPM1‐PUM1 ‐ LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule
Goto, K., Pissaloux, D., Durand, L., Tirode, F., Guillot, B., & de la Fouchardière, A. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12884 · Cited by 23
Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
Wei, T., Zhang, J., Li, J., Chen, Q., Zhi, X., Wei, T., Ma, J., Yang, J., Lou, Y., Ma, T., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12757 · Cited by 24
Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
Gaiani, F., Marchesi, F., Negri, F., Greco, L., Malesci, A., de’Angelis, G. L., & Laghi, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105246 · Cited by 24
Treatment for postoperative recurrence of pancreatic cancer: a narrative review
Okusaka, T. (2022) · Chinese Clinical Oncology · doi:10.21037/cco-21-87 · Cited by 23
Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma
Cui, H., Zhou, Y., Wang, F., Cheng, C., Zhang, W., Sun, R., Zhang, L., Bi, Y., Guo, M., Zhou, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33994-3 · Cited by 24
Immunometabolic coevolution defines unique microenvironmental niches in ccRCC
Tang, C., Xie, A. X., Liu, E., Kuo, F., Kim, M., Dinatale, R., Golkaram, M., Chen, Y.-B., Gupta, S., Motzer, R., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.005 · Cited by 25
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?
Feingold, P. L., Kwong, M. L. M., Sabesan, A. C., Sorber, R. A., & Rudloff, U. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.098 · Cited by 23
Chromosomal Copy Number Aberrations in Colorectal Metastases Resemble Their Primary Counterparts and Differences Are Typically Non-Recurrent
Mekenkamp, L. J., Haan, J. C., Israeli, D., Essen, H. F. H. V., Dijkstra, J. R., van Cleef, P., Punt, C. J. A., Meijer, G. A., Nagtegaal, I. D., & Ylstra, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086833 · Cited by 23
Next-Generation Sequencing: Application in Liver Cancer—Past, Present and Future?
Marquardt, J. U., & Andersen, J. B. (2012) · Biology · doi:10.3390/biology1020383 · Cited by 23
Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1
Thomas, L. E., Mautner, V., Cooper, D. N., & Upadhyaya, M. (2012) · Human Genomics · doi:10.1186/1479-7364-6-18 · Cited by 26
Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression
Moravec, R., Divi, R. L., & Verma, M. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i6.235 · Cited by 24
MDM2 copy number increase: a poor prognostic, molecular event in esophageal squamous cell carcinoma
Sawada, R., Maehara, R., Oshikiri, T., Nakamura, T., Itoh, T., Kodama, Y., Kakeji, Y., & Zen, Y. (2019) · Human Pathology · doi:10.1016/j.humpath.2019.04.002 · Cited by 23
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an “exceptional responder” lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responsePreprint
Biswas, R., Gao, S., Cultraro, C. M., Maity, T. K., Venugopalan, A. K., Abdullaev, Z., Shaytan, A. К., Carter, C. A., Thomas, A., Rajan, A., et al. (2016) · Molecular Case Studies · doi:10.1101/mcs.a001263 · Cited by 22
A recombinant chimeric protein specifically induces mutant KRAS degradation and potently inhibits pancreatic tumor growth
Pan, T., Zhang, Y., Zhou, N., He, X., Chen, C., Liang, L., Duan, X., Lin, Y., Wu, K., & Zhang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.9996 · Cited by 21
High DNA Methylation Pattern Intratumoral Diversity Implies Weak Selection in Many Human Colorectal Cancers
Siegmund, K. D., Marjoram, P., Tavaré, S., & Shibata, D. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021657 · Cited by 22
New DNA sequencing technologies open a promising era for cancer research and treatment
Sastre, L. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0658-1 · Cited by 22
The Challenge and Promise of the Genomic Era
Sledge, G. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.0088 · Cited by 22
Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models
Hong, B., Yang, Y., Guo, S. J., Duoerkun, S., Deng, X., Chen, D., Yu, S., Qian, W., Li, Q., Li, Q., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17765 · Cited by 21
Engineering Multidimensional Evolutionary Forces to Combat Cancer
McCoach, C. E., & Bivona, T. G. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1196 · Cited by 23
Nature or Nurture? Role of the Bone Marrow Microenvironment in the Genesis and Maintenance of Myelodysplastic Syndromes
Mian, S. A., & Bonnet, D. A. (2021) · Cancers · doi:10.3390/cancers13164116 · Cited by 22
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division
Zhang, C., & Pellman, D. S. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070620-094029 · Cited by 23
Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
Zhu, J., Huang, Q., Peng, X., Luo, C. H., Liu, S., Liu, Z., Wu, X., & Luo, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.799475 · Cited by 22
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care
Casolino, R., Corbo, V., Beer, P. A., Hwang, C., Paiella, S., Silvestri, V., Ottini, L., & Biankin, A. V. (2022) · Cancers · doi:10.3390/cancers14133239 · Cited by 24
Colorectal cancer liver metastasis: genomic evolution and crosstalk with the liver microenvironment
Liu, Q.-L., Zhou, H., Zhou, Z., & Chen, H. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10107-0 · Cited by 22
The specific contributions of cohesin-SA1 to cohesion and gene expression
Cuadrado, A., Remeseiro, S., Goméz-López, G., Pisano, D. G., & Losada, A. (2012) · Cell Cycle · doi:10.4161/cc.20318 · Cited by 22
Genome instability mechanisms and the structure of cancer genomes
Cassidy, L. D., & Venkitaraman, A. R. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.02.003 · Cited by 22
Encapsulated Cells Expressing a Chemotherapeutic Activating Enzyme Allow the Targeting of Subtoxic Chemotherapy and Are Safe and Efficacious: Data from Two Clinical Trials in Pancreatic Cancer
Löhr, M. J., Haas, S., Kröger, J., Friess, H., Höft, R., Goretzki, P. E., Peschel, C., Schweigert, M., Salmons, B., & Günzburg, W. H. (2014) · Pharmaceutics · doi:10.3390/pharmaceutics6030447 · Cited by 22
The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer
Guerrero, E., & Ahmed, M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.11.015 · Cited by 24
Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway
Li, Y., Ohira, M., Zhou, Y., Xiong, T., Luo, W., Yang, C., Li, X., Gao, Z., Zhou, R., Nakamura, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18079 · Cited by 22
Prediagnostic Leukocyte Telomere Length and Pancreatic Cancer Survival
Hamada, T., Yuan, C., Bao, Y., Zhang, M., Khalaf, N. I., Babić, A., Morales‐Oyarvide, V., Cochrane, B. B., Gaziano, J. M., Giovannucci, E. L., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0577 · Cited by 23
Genomic dynamics associated with malignant transformation in IDH1 mutated gliomas
Park, C., Park, I. H., Lee, S., Sun, C.-H., Koh, Y., Park, S.-H., Eun, K. J., Yun, H., & Lee, S.-H. (2015) · Oncotarget · doi:10.18632/oncotarget.6189 · Cited by 22
From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity
Gambara, G., Gaebler, M., Keilholz, U., Regenbrecht, C. R. A., & Silvestri, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00077 · Cited by 23
Decoding the mechanisms behind second primary cancers
Zeng, M., Lin, A., Jiang, A., Qiu, Z., Zhang, H., Chen, S., Xu, M., Liu, Z., Cheng, Q., Zhang, J., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06151-9 · Cited by 21
A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Sciver, R. E. V., Lee, M., Lee, C. G. L., Lafever, A., Svyatova, E. A., Kanda, K., Collier, A. L., van Reesema, L. L. S., Tang-Tan, A. M., Zheleva, V. P., et al. (2018) · Cancers · doi:10.3390/cancers10050142 · Cited by 21
Unstable Genome and Transcriptome Dynamics during Tumor Metastasis Contribute to Therapeutic Heterogeneity in Colorectal Cancers
Cho, S., Chae, J., Na, D., Kang, W., Lee, A., Min, S., Kang, J., Choi, B., Lee, J. L., Sung, C. O., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3460 · Cited by 22
Evolution of Metastasis Study Models toward Metastasis‐On‐A‐Chip: The Ultimate Model?
Ruiz‐Espigares, J., Nieto, D., Moroni, L., Jiménez, G., & Marchal, J. A. (2021) · Small · doi:10.1002/smll.202006009 · Cited by 23
Tumor Microenvironment
Maru, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-1757-7_11 · Cited by 25
Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes
Guo, P., Teng, T., Liu, W., Fang, Y., Wei, B., Feng, J., & Huang, H. (2022) · International Journal of Cancer · doi:10.1002/ijc.34208 · Cited by 21
Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
Guan, S., Deng, G., Sun, J., Han, Q., Lv, Y., Xue, T., Ding, L., Yang, T., Qian, N., & Dai, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.926260 · Cited by 21
Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines
Ma, Y., Schulz, B., Trakooljul, N., Alammar, M., Sekora, A., Sender, S., Hadlich, F., Zechner, D., Weiß, F. U., Lerch, M. M., et al. (2022) · Cancers · doi:10.3390/cancers14184467 · Cited by 21
Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment
Apostoli, A. J., & Ailles, L. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1083944 · Cited by 21
Large-Scale Protein Profiling in Human Cell Lines Using Antibody-Based Proteomics
Fagerberg, L., Strömberg, S., El‐Obeid, A., Gry, M., Nilsson, K., Uhlén, M., Pontén, F., & Asplund, A. (2011) · Journal of Proteome Research · doi:10.1021/pr200259v · Cited by 21
Increased genome instability in human DNA segments with self-chains: homology-induced structural variations via replicative mechanisms
Zhou, W., Zhang, F., Chen, X., Shen, Y., Lupski, J. R., & Li, J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt113 · Cited by 22
Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
Yang, J., & Zeng, Y. (2015) · PubMed · Cited by 21
The rise of genomic profiling in ovarian cancer
Previs, R. A., Sood, A. K., Mills, G. B., & Westin, S. N. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1259069 · Cited by 23
Telomere biology in aging and cancer: early history and perspectives
Hayashi, M. (2017) · Genes & Genetic Systems · doi:10.1266/ggs.17-00010 · Cited by 23
Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer
Roggisch, J., Ecke, T., & Koch, S. (2019) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2019.08.007 · Cited by 21
Aberration of ARID1A Is Associated With the Tumorigenesis and Prognosis of Sporadic Nonfunctional Pancreatic Neuroendocrine Tumors
Han, X., Chen, W., Chen, P., Zhou, W., Rong, Y., Lv, Y., Li, J., Ji, Y., Chen, W., Lou, W., et al. (2020) · Pancreas · doi:10.1097/mpa.0000000000001535 · Cited by 21
Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs
Zolotovskaia, M., Sorokin, M., Garazha, A., Borisov, N., & Buzdin, A. A. (2019) · Methods in molecular biology · doi:10.1007/978-1-0716-0138-9_16 · Cited by 20
Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma
Min, Q., Wang, Y., Wu, Q., Li, X., Teng, H., Fan, J., Cao, Y., Fan, P., & Zhan, Q. (2021) · JCI Insight · doi:10.1172/jci.insight.150203 · Cited by 20
Therapeutic implications of cancer stem cells in prostate cancer
Banerjee, P., Kapse, P., Siddique, S., Kundu, M., Choudhari, J., Mohanty, V., Malhotra, D., Gosavi, S., Gacche, R. N., & Kundu, G. C. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0714 · Cited by 19
Intratumoral stages of metastatic cells: A synthesis of ontogeny, Rho/Rac GTPases, epithelial‐mesenchymal transitions, and more
Bustelo, X. R. (2012) · BioEssays · doi:10.1002/bies.201200041 · Cited by 20
Homology-mediated end-capping as a primary step of sister chromatid fusion in the breakage-fusion-bridge cycles
Marotta, M. L., Chen, X., Watanabe, T., Faber, P. W., Diede, S. J., Tapscott, S. J., Tubbs, R., Kondratova, A. A., Stephens, R. M., & Tanaka, H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt762 · Cited by 23
Advances in understanding the molecular mechanism of pancreatic cancer metastasis
Du, Y., Liu, Z., You, L., Wu, W., & Zhao, Y.-P. (2016) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(15)60033-9 · Cited by 20
Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
Gao, Y., Zhu, Y., & Yuan, Z. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.16734 · Cited by 21
Pancreatic carcinogenesis — several small steps or one giant leap?
Reiter, J. G., & Iacobuzio–Donahue, C. A. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.190 · Cited by 21
Self-citation
Whole-genome sequencing of prostate cancer reveals novel mutation-driven processes and molecular subgroups
Liang, C., Niu, L., Xiao, Z., Zheng, C., Shen, Y., Shi, Y., & Han, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117218 · Cited by 21
Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system.
Rao, Q., Zhang, Q., Zheng, C., Dai, W., Zhang, B., Ionescu‐Zanetti, C., Lin, Z., & Zhang, L. (2017) · PubMed Central · Cited by 19
Risk factors of pancreatic cancer and their possible uses in diagnostics
Lang, J., Kunovský, L., Kala, Z., & Trna, J. (2020) · Neoplasma · doi:10.4149/neo_2020_200706n699 · Cited by 20
The niche under siege: novel targets for metastasis therapy
Santamaria‐Martínez, A., & Huelsken, J. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12024 · Cited by 20
Tracing Dynamics and Clonal Heterogeneity of Cbx7-Induced Leukemic Stem Cells by Cellular Barcoding
Klauke, K., Broekhuis, M., Weersing, E., Dethmers-Ausema, A., Ritsema, M., González, M. V., Zwart, E., Bystrykh, L. V., & de Haan, G. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.10.012 · Cited by 18
Pancreatic cancer-improved care achievable
Buanes, T. A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10405 · Cited by 19
A Forward Look At Noninvasive Prenatal Testing
Liu, L., Li, K., Fu, X., Chung, C., & Zhang, K. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.008 · Cited by 19
Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes
Jacoby, M. A., & Walter, M. J. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.18 · Cited by 20
Pancreatic Cancer Screening
Das, K. K., & Early, D. S. (2017) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-017-0149-8 · Cited by 19
Complexity of the genomic landscape of renal cell carcinoma: Implications for targeted therapy and precision immuno-oncology
Sanfrancesco, J. M., & Liang Cheng, C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.09.011 · Cited by 20
Metastatic tumor cells – genotypes and phenotypes
Gao, D., Mittal, V., Ban, Y., Lourenço, A. R., Yomtoubian, S., & Lee, S. B. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1513-3 · Cited by 20
Pre-Operative Prediction of Mediastinal Node Metastasis Using Radiomics Model Based on 18F-FDG PET/CT of the Primary Tumor in Non-Small Cell Lung Cancer Patients
Zheng, K., Wang, X., Jiang, C., Tang, Y., Fang, Z., Hou, J., Zhu, Z., & Hu, S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673876 · Cited by 19
Primary testicular Ph-positive B lymphoblastic lymphoma: an unusual presentation and review
Zhu, J., Zhang, S., Zhu, L., Li, X., Wang, Y., Duan, Y., & Huang, W. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056412 · Cited by 19
DNA Repair Pathway Selection Caused by Defects in TEL1, SAE2, and De Novo Telomere Addition Generates Specific Chromosomal Rearrangement Signatures
Putnam, C. D., Pallis, K., Hayes, T. K., & Kolodner, R. D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004277 · Cited by 19
Origin of metastases: Subspecies of cancers generated by intrinsic karyotypic variations
DUESBERG, P. H., Iacobuzio–Donahue, C. A., Brosnan‐Cashman, J. A., McCormack, A. A., Mandrioli, D., & Chen, L. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19580 · Cited by 19
Self-citation
The Diverse Effects of Complex Chromosome Rearrangements and Chromothripsis in Cancer Development
de Pagter, M. S., & Kloosterman, W. P. (2015) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-20291-4_8 · Cited by 21
Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway
Wang, Z., Li, Y., Fan, L., Zhao, Q., Tan, B., Liu, R., & Li, F. (2019) · Neoplasma · doi:10.4149/neo_2019_190404n295 · Cited by 19
Combination Chemoradiation Therapy: The Whole Is More Than the Sum of the Parts
Mamon, H. J., & Tepper, J. E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.3108 · Cited by 19
Pancreatic organoids as cancer avatars for true personalized medicine
Gout, J., Ekizce, M., Roger, É., & Kleger, A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115642 · Cited by 20
Dissecting genetic and environmental mutation signatures with model organisms
Segovia, R., Tam, A., & Stirling, P. C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.04.001 · Cited by 20
Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma
Qian, Y., Gong, Y., Zou, X., Liu, Y., Chen, Y., Wang, R., Dai, Z., Tasiheng, Y., Lin, X., Wang, X., et al. (2022) · Oncogenesis · doi:10.1038/s41389-022-00411-9 · Cited by 18
The molecular landscape of pancreatic ductal adenocarcinoma
Sivapalan, L., Kocher, H. M., Ross‐Adams, H., & Chelala, C. (2022) · Pancreatology · doi:10.1016/j.pan.2022.07.010 · Cited by 21
Genetics, Genomics and Emerging Molecular Therapies of Pancreatic Cancer
Liu, J., Mroczek, M., Mach, A., Stępień, M., Aplas, A., Pronobis‐Szczylik, B., Bukowski, S., Mielczarek, M., Gajewska, E., Topolski, P., et al. (2023) · Cancers · doi:10.3390/cancers15030779 · Cited by 18
Insights into the metastatic cascade through research autopsies
Hessey, S., Fessas, P., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.03.002 · Cited by 19
Oncogenic structural aberration landscape in gastric cancer genomes
Saito-Adachi, M., Hama, N., Totoki, Y., Nakamura, H. K., Arai, Y., Hosoda, F., Rokutan, H., Yachida, S., Kato, M., Fukagawa, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39263-1 · Cited by 18
Self-citation
A System-Level Pathway-Phenotype Association Analysis Using Synthetic Feature Random Forest
Pan, Q., Hu, T., Malley, J. D., Andrew, A. S., Karagas, M. R., & Moore, J. H. (2014) · Genetic Epidemiology · doi:10.1002/gepi.21794 · Cited by 18
KISS1 Associates with Better Outcome via Inhibiting Matrix Metalloproteinase-9 in Colorectal Liver Metastasis
Zhu, C., Takasu, C., Morine, Y., Bando, Y., Ikemoto, T., Saito, Y., Yamada, S., Imura, S., Arakawa, Y., & Shimada, M. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4891-7 · Cited by 18
Untangling the genetics from the epigenetics in pancreatic cancer metastasis
Vakoc, C. R., & Tuveson, D. A. (2017) · Nature Genetics · doi:10.1038/ng.3798 · Cited by 18
Limited impact of intratumour heterogeneity on molecular risk assignment in endometrial cancer
van Esterik, M., van Gool, I. C., de Kroon, C. D., Nout, R. A., Creutzberg, C. L., Smit, V. T. H. B. M., Bosse, T., & Stelloo, E. (2017) · Oncotarget · doi:10.18632/oncotarget.16067 · Cited by 18
A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics
Stanta, G., & Bonin, S. (2017) · Pathobiology · doi:10.1159/000477813 · Cited by 18
Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia
Weng, Z., Spies, N., Zhu, S., Newburger, D. E., Kashef-Haghighi, D., Batzoglou, S., Sidow, A., & West, R. B. (2015) · Genome Medicine · doi:10.1186/s13073-015-0146-2 · Cited by 18
Impact of intra-individual molecular heterogeneity in personalized treatment of hepatocellular carcinoma
Villanueva, A., & Llovet, J. M. (2012) · Hepatology · doi:10.1002/hep.26124 · Cited by 18
High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation
Huang, R., Liu, Y., Wang, K., Wang, Z., Zhang, C., Zhang, W., Zhao, Z., Li, G., Huang, L., Chang, Y., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13627 · Cited by 18
Identification of Galectin-7 as a crucial metastatic enhancer of squamous cell carcinoma associated with immunosuppression
An, J., Nagaki, Y., Motoyama, S., Kuze, Y., Hoshizaki, M., Kemuriyama, K., Yamaguchi, T., Ebihara, T., Minamiya, Y., Suzuki, Y., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02525-1 · Cited by 17
2-[18F]FDG PET-based quantification of lymph node metabolic heterogeneity for predicting lymph node metastasis in patients with colorectal cancer
Xu, L., Huang, G., Wang, Y., Huang, G., Liu, J., & Chen, R. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06578-6 · Cited by 17
Moduli Spaces of Phylogenetic Trees Describing Tumor Evolutionary Patterns
Zairis, S., Khiabanian, H., Blumberg, A. J., & Rabadán, R. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-09891-3_48 · Cited by 17
The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma
Shoji, S., Nakano, M., Sato, H., Tang, X. Y., Osamura, Y. R., Terachi, T., Uchida, Τ., & Takeya, K. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9612-7 · Cited by 17
Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer
Burotto, M., Singh, N. K., Heery, C. R., Gulley, J. L., & Madan, R. A. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00351 · Cited by 17

Authors: Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., McBride, D. J., Varela, I., Nik-Zainal, S. A., Leroy, C., Jia, M., Menzies, A., Butler, A. P., Teague, J. W., Griffin, C. A., Burton, J., Swerdlow, H., Quail, M. A., Stratton, M. R., Iacobuzio-Donahue, C., & Futreal, P. A.
Affiliations: University of Cambridge (GB)
Johns Hopkins University (US)
Wellcome Sanger Institute (GB)
Institute of Cancer Research (GB)
Corresponding author: Futreal, P. Andrew
ORCID: Campbell, Peter J.
Yachida, Shinichi
Pleasance, Erin D.
Latimer, Calli
McLaren, Stuart
McBride, David J.
Varela, Ignacio
Jia, Mingming
Menzies, Andrew
Teague, Jon W.
Swerdlow, Harold
Quail, Michael A.
Stratton, Michael R.
Futreal, P. Andrew
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2010-10
Volume: 467
Issue: 7319
Pages: 1109-1113
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature09460
PMC: PMC3137369
OpenAlex: W2066254965
Cited by: 1,317
References: 30
Citations by year: 2026: 10 · 2025: 31 · 2024: 33 · 2023: 51 · 2022: 47 · 2021: 86 · 2020: 69 · 2019: 72 · 2018: 75 · 2017: 117 · 2016: 104 · 2015: 119 · 2014: 153 · 2013: 109 · 2012: 135
FWCI: 34.92
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Skip Viragh Foundation
Uehara Memorial Foundation
Wellcome Trust (077012/Z/05/Z, 088340, 093867, WT088340MA)
National Institutes of Health
National Cancer Institute (R01CA140599, K08CA106610, CA140599, CA106610)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: pancreatic cancer, metastasis, genomic instability, chromosomal rearrangements, clonal evolution, telomere dysfunction, G1/S checkpoint, copy number alterations, tumor progression, early detection, therapeutic target, interpatient heterogeneity, tumour dissemination, somatic mutations, GATA4, GATA3
MeSH terms: Adenocarcinoma, Cell Cycle, Clone Cells, DNA Mutational Analysis, Humans, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Organ Specificity, Pancreatic Neoplasms, Mutagenesis, Telomere, Disease Progression, Cell Lineage, Evolution, Molecular, Genomic Instability, Genes, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks